Literature DB >> 28917464

The majority of patients presenting with vitiligo have a clinical sign of activity.

Nader Aboul-Fettouh1, Jorge Hinojosa1, Andrea Tovar-Garza1, Amit G Pandya2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28917464     DOI： 10.1016/j.jaad.2017.05.027

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China.

Authors:  Li Zhang; Shujun Chen; Yuli Kang; Xiuxiu Wang; Fang Yan; Min Jiang; Qianqian Wang; Ziqi Liu; Chengfeng Zhang; Leihong Xiang
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

Review 2.  Autologous non-cultured melanocyte-keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives.

Authors:  Dalia Bassiouny; Samia Esmat
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-26

Review 3.  Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.

Authors:  Yinghan Wang; Shuli Li; Chunying Li
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-20       Impact factor: 8.667

4.  Reliability and validity of the Vitiligo Signs of Activity Score (VSAS).

Authors:  N van Geel; T Passeron; A Wolkerstorfer; R Speeckaert; K Ezzedine
Journal:  Br J Dermatol       Date:  2020-03-29       Impact factor: 9.302
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.